ABT vs GILD
Abbott Laboratories vs Gilead Sciences — AI-powered side-by-side comparison
| Metric | ABT | GILD |
|---|---|---|
| AI Score | 55 | 60 |
| Price | $100.58 | $130.38 |
| P/E Ratio | 27.69× | 17.56× |
| ROE | 0.1% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 0.8% |
| Debt / Equity | 0.65× | 0.94× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 64.7 | 45.5 |
| Beta | 0.607 | 0.343 |
| Expected Upside | +6.9% | +20.8% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABT Full Analysis
GILD Full Analysis